SCHEMBL7084362

SCHEMBL7084362

c1ccc2c(c1)O[C](C1c3ccccc3-c3ccccc31)O2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
ATM Q13315 2/20 0.39
GPR3 P46089 1/20 0.37
CYP2C9 P11712 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
ALOX5 P09917 1/20 0.34
ALOX15 P16050 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPK1 P28482 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28627118 0.76 MAOA (0.45) HTR2AMAOAMAOBATMGPR3
SCHEMBL8516774 0.70 MAOA (0.54) HTR2AMAOAMAOBATMGPR3
SCHEMBL27885617 0.69 HTR2A (0.52) HTR2AATMGPR3CYP1A2CYP2D6
SCHEMBL29116619 0.67 HTR2A (0.50) HTR2AMAOAGPR3CYP1A2KDM4E
SCHEMBL8516771 0.67 MAOA (0.50) HTR2AMAOAMAOBATMCYP2C9
SCHEMBL25171318 0.65 LMNA (0.54) HTR2AMAOAMAOBGPR3CYP1A2
SCHEMBL1304934 0.65 HTR2A (0.48) HTR2AGPR3CYP1A2CYP2D6HDAC3
SCHEMBL29490167 0.65 HTR2A (0.48) HTR2AGPR3CYP1A2CYP2D6HDAC3
SCHEMBL70993 0.65 LMNA (0.54) HTR2AMAOAMAOBGPR3CYP1A2
SCHEMBL9297178 0.65 HTR2A (0.48) HTR2AMAOAGPR3CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030199542-A1 Farnesyltransferase inhibitors WEINSTOCK, STEVEN F. 2003-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030199542-A1 Farnesyltransferase inhibitors FNTA, FNTB, LCAT HTR2A 4721/4885MAOA 2168/4885MAOB 1531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.